Curis
CRIS
#10306
Rank
HK$84.65 M
Marketcap
HK$6.55
Share price
-15.97%
Change (1 day)
-77.43%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -HK$28.58

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$28.60. In 2024 the company made an earnings per share (EPS) of -HK$54.78 an increase over its 2023 EPS that were of -HK$70.36.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$28.58-47.83%
2024-HK$54.78-22.15%
2023-HK$70.36-26.17%
2022-HK$95.3022.3%
2021-HK$77.92-25.37%
2020-HK$104.42-30.93%
2019-HK$151.17-2.02%
2018-HK$154.29
2016-HK$350.66-10%
2015-HK$389.62138.1%
2014-HK$163.6440%
2013-HK$116.89-25%
2012-HK$155.8566.67%
2011-HK$93.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
HK$18.55-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$10.99-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.81-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.34-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.40-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.14-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$87.59 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA